If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
131.60    1.00 (0.77%)
Bid:
131.20
Ask:
131.40
Spread: 0.20 (0.152%)
Market Cap: £269.90m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Trading update

22 Nov 2017 07:00

RNS Number : 1437X
Forterra plc
22 November 2017
 

 

22 November 2017

Forterra plc

Trading update

 

Forterra plc, a leading UK producer of manufactured masonry products, provides this trading update covering the period from 1 July to 31 October 2017.

 

Trading in the period has continued to be underpinned by good activity levels in the new build residential sector, resulting in double digit growth of brick and aggregate block volumes for the ten months to October 2017 compared with the same period last year. Overall Group revenue for the ten month period was 12% ahead of last year after excluding the Bison acquisition.

 

The Group completed the acquisition of the trade and certain assets of Bison Manufacturing Ltd in September 2017. The integration of the business, which includes the transfer of certain product lines between the two existing Forterra precast concrete facilities and the new Bison facility in order to improve efficiency and maximise potential, is progressing to plan. The Group's precast concrete business has been rebranded as Bison Precast, recognising the strength of the Bison brand in the marketplace.

 

Following the completion of the investment project at the Group's Claughton brick facility in Lancashire resulting in an increased capacity of over 5 million bricks per annum (c11% of the existing plant capacity), production commenced in the second half in line with plan. A kiln at the nearby Accrington facility has been relit and the plant is expected to build up to full production utilising both kilns during 2018.

 

The Group continues to generate a strong level of operating cashflow and this, after the payment of £20m for the Bison acquisition and dividends of £13.8m, resulted in net debt of £87.2m at 31 October 2017 compared with £92.3m at the start of the year.

 

Based on the good trading performance in the year to date and the forward order book, the Board's expectations for the full year remain unchanged.

 

 

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Stephen Harrison (CEO)

Shatish Dasani (CFO)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

 

 

Further information relating to the Company and its group can be found at www.forterraplc.co.uk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBUBDBRDDBGRB
Date   Source Headline
25th Nov 20217:00 amRNSTrading Update
2nd Nov 20215:12 pmRNSEmployee Benefit Trust Share Purchase
1st Nov 20211:51 pmRNSDirector Declaration
13th Oct 20217:06 amRNSHolding(s) in Company
7th Oct 20215:12 pmRNSDirector/PDMR Shareholding
6th Oct 20217:51 amRNSHolding(s) in Company
5th Oct 20215:49 pmRNSEmployee Benefit Trust Share Purchase
28th Sep 20219:28 amRNSEmployee Benefit Trust Share Purchase
23rd Sep 20218:33 amRNSHolding(s) in Company
21st Sep 20218:11 amRNSHolding(s) in Company
17th Sep 202111:21 amRNSDirector Declaration
3rd Sep 20213:22 pmRNSEmployee Benefit Trust Share Purchase
27th Aug 20212:58 pmRNSDirector/PDMR Shareholding
27th Aug 202111:15 amRNSDirector Declaration
26th Aug 20217:00 amRNSDisposal of Swadlincote site
9th Aug 20219:32 amRNSHolding(s) in Company
3rd Aug 20212:49 pmRNSEmployee Benefit Trust Share Purchase
29th Jul 20217:56 amRNSProgressive publishes new research
29th Jul 20217:00 amRNSHalf-year Report
13th Jul 20216:03 pmRNSDirector/PDMR Shareholding
5th Jul 202111:22 amRNSEmployee Benefit Trust Share Purchase
15th Jun 20219:56 amRNSDirector/PDMR Shareholding
7th Jun 20219:24 amRNSEmployee Benefit Trust Share Purchase
27th May 20213:45 pmRNSDirector/PDMR Shareholding
18th May 20213:45 pmRNSAnnual General Meeting 2021 Results
18th May 202110:28 amRNSProgressive publishes new research
18th May 20217:00 amRNSTrading Statement
6th May 20217:00 amRNSEmployee Benefit Trust Share Purchase
30th Apr 20214:07 pmRNSHolding(s) in Company
30th Apr 20211:11 pmRNSGrant under Performance Share Plan
9th Apr 20213:46 pmRNSDirector/PDMR Shareholding
9th Apr 202110:56 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSAnnual Report 2020 and Notice of AGM 2021
8th Apr 20213:31 pmRNSEmployee Benefit Trust Share Purchase
1st Apr 202110:59 amRNSDirector/PDMR Shareholding
30th Mar 20211:14 pmRNSDirector/PDMR Shareholding
25th Mar 20212:41 pmRNSDirector/PDMR Shareholding
22nd Mar 20213:55 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNS2020 FULL YEAR RESULTS
4th Mar 20217:24 amRNSHolding(s) in Company
3rd Mar 202110:36 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSEmployee Benefit Trust Share Purchase
17th Feb 20213:16 pmRNSHolding(s) in Company
15th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20212:16 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:17 pmRNSEmployee Benefit Trust Share Purchase
1st Feb 20214:48 pmRNSDirector/PDMR Shareholding
28th Jan 202112:38 pmRNSHolding(s) in Company
27th Jan 20213:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.